NEW YORK CITY, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...

Teva Pharmaceutical Industries Ltd.'s bid to dismiss antitrust claims should be denied in a case where Mylan Pharmaceuticals Inc. alleges the company unlawfully delayed a generic version of a multiple ...

New York, New York-- (Newsfile Corp. - March 1, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against ICON plc (NASDAQ: ICLR) and certain of ...

Granules India has announced that Sethu Madhavan Sankaran has resigned from the position of Senior Vice President & Head-API ...

Stanley Druckenmiller is a retired hedge fund manager of Duquesne Capital, which focuses on macro investment strategy. His fund constantly delivered high returns, and in 2010, when the fund failed to ...

The global generic oncology drugs market is set for consistent growth over the next decade, with sales anticipated to rise from USD 23,743.5 million in 2025 to USD 30,606.3 million by 2035, reflecting ...

2025 Healthcare & Pharmaceuticalscategory India's Sun Pharma aims to launch its obesity drug in five years, managing director says February 28, 2025 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

ICICI Pru Regular Savings Fund (G) 34.54 2,03,104 1.10 ICICI Pru Regular Savings Fund (IDCW-Q) 34.54 2,03,104 1.10 ICICI Pru Regular Savings Fund (IDCW-HY) 34.54 2,03 ...

Conversely, 52 stocks, including KDDL, Sandur Manganese, Pennar Industries, Taj GVK Hotels, IKIO Lighting, and Benares Hotels, yielded returns between 10-40%. During Trump’s 2017-2021 tenure, Indian ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,721.04 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...